GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
U

Ucb UCB.BR · EUR

Health Care · Euronext Brussels · 🇧🇪 Belgium

Compare

298.80

+2.72%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Ucb — daily UCB

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Ucb on TradingView ↗
Market value
€58.27bn
Last close × shares
Volume
323.9k
Shares, 9 Nov 2026
Price to earnings
35.4
Dividend yield
0.51%

About Ucb

Its shares trade on Euronext Brussels under the ticker UCB.BR. It has been listed since 2 January 1987. In the fiscal year to 31 December 2025, it reported revenue of €7.74bn and net income of €1.56bn. At that date it held total assets of €18.16bn and shareholders' equity of €10.87bn.

UCB SA engages in the research, development, and commercialization of pharmaceutical and biotechnology products. The company is headquartered in Anderlecht, Bruxelles-Capitale. In the area of central nervous system disorders, the Company is focused on epilepsy, diabetic neuropathic pain, multiple sclerosis, fibromyalgia, restless legs syndrome and Parkinson’s disease, and the area of immunology includes, bone loss disorders, Crohn’s disease, rheumatoid arthritis and respiratory disease. In addition to its core fields of business, Ucb SA delivers molecule solutions to specialists for use in the treatment of severe diseases. Its product portfolio includes drugs, such as Neupro, Vimpat, Cimzia, among others. Ucb SA also operates in primary care to support specialist products that are administered by primary care physicians.

Figures and description from our data supplier, not checked against the company's own report.

More about Ucb →

Latest on Ucb

Our reporting

Next results

25 Feb 2027

Due on 25 Feb 2027. Analysts expect earnings of 7.09 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Ucb's ticker?

Ucb trades as UCB.BR on Euronext Brussels, under ISIN BE0003739530.

What was Ucb's last closing price?

298.80 on 9 Nov 2026. The figure is in EUR and is never converted.

When does Ucb next report results?

Results are expected on 25 Feb 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.